Clear Street

We would like to announce some exciting management updates at Clear Street Group. Jonathan Daplyn takes the reigns as Chief Operating Officer and Andrew Volz, CFA becomes our Chief Commercial Officer. We also welcome Raja Bhatia to the team as Chief Technology Officer of Clear Street Active, Trading and Risk. These moves reflect our dedication to putting clients and tech-enablement at the heart of everything we do! Read the press release here: https://lnkd.in/de5Ym8qB

We're headed down south for iConnections' #GlobalAlts Miami next week! Stop by booth 1518 at the Miami Beach Convention Center and cabana 5 at the Fontainebleau Miami Beach Hotel from January 27-30 to meet the Clear Street team. Interested in meeting? Reach out to Ed Tilly, Andrew Volz, CFA, Bernie Robinson, Bjorn Franson, Kevin Weir, Reshma K., Victoria Harinxma-Jenkins, George Jamgochian, Rich Mormile, Claire Reilly, Austin A. Graham, Chris Smith and Steve Trimble.

This week, CEO Ed Tilly traveled to London Metal Exchange to celebrate Clear Street’s Category 1 Ring membership. With our global client base at the center of everything we do, our partnership with LME strengthens our suite of products and services, as we enable our customers to trade in all products, in all markets worldwide.

Clear Street is bringing fresh perspectives and deep scientific expertise to healthcare and biotech equity research. Check out our article today in IR Magazine and join us next week in San Francisco for our launch party! Request an invite: https://bit.ly/40pxNYJ

Clear Street is excited to attend and sponsor iConnections #GlobalAltsMiami January 27-30.  Meet us at booth 1518 at the Miami Beach Convention Center and cabana 5 at the Fontainebleau Miami Beach Hotel.  We look forward to a week of connecting with industry peers at the world's largest cap intro event. Also attending? Reach out to our team to connect at the conference: Andrew Volz, CFA, Bernie R., Bjorn Franson, Kevin Weir, Jud Howson, Reshma K., Victoria Harinxma-Jenkins, George Jamgochian, Rich Mormile, Claire Reilly, Austin A. Graham, Chris Smith and Steve Trimble.

Congratulations, Jason Price, Product Manager, on reaching five years at Clear Street! Your dedication, hard work, and valuable contributions have had a lasting impact on your team and the firm. Here's to many more years of success and continued collaboration! Interested in joining our team? Visit: https://lnkd.in/eQ6P6dZn

💻 Join us for a webinar on the future of ETFs! 💻 The WFE and Clear Street are bringing together a panel of ETF experts to discuss the current trends, opportunities and pain points they're seeing in the space, as well as the regulatory implications post-election and a market outlook for 2025. Moderated by our Regulatory Affairs Manager, Charlie Ryder, we'll also hear from Thomas Bonville, Head of Derivative Sales at Clear Street, Alison Hennessy, Head of ETP Listings at Nasdaq, Matthew Tuttle, CEO and CIO of Tuttle Capital Management LLC and William Rhind, Founder and CEO of GraniteShares ETFs They'll drill down on how monetary policy, regulatory policies, inflation, and the new administration could impact the ETFs industry. 🖱️ Click here to register: https://bit.ly/41WWUDN

Yesterday, Ashley DeSimone, Clear Street’s Chief Marketing Officer, Claire Reilly, Director, Capital Introduction, and Jacinda Fahey, CEO of Clear Street UK and EU, hosted a table talk session with Tetiana Kyslytsyna, CAIA, UBS Hedge Fund Solutions, at 100 Women In Finance's "A Decade of Impact: Celebrating 10 Years of 100WF FundWomen" event at the NYSE. They explored shifts in hedge fund portfolio asset allocation in today’s market environment, offering valuable insights from a Capital Introduction perspective. Thank you to all the women who attended our table sessions and shared their knowledge during our insightful conversation. Jeanette Forkan, Sarah Finley, Kellan Brown

We are excited to announce the expansion of our recently launched equity research offering with the addition of Healthcare Equity Research.  Initially focused on the biotechnology sector, our expanded research offering complements our full suite of existing products and demonstrates our commitment to providing capabilities that align with our clients’ evolving needs.  To initiate coverage, Clear Street has appointed Kaveri Pohlman, PhD, MBA, and Bill Maughan, Ph.D., as Managing Directors and Senior Equity Analysts, reporting to Mara Goldstein, Director of Research. Healthcare coverage launch includes: • CARGO Therapeutics (Nasdaq: CRGX) • Century Therapeutics, Inc (Nasdaq: IPSC) • Cullinan Therapeutics (Nasdaq: CGEM) • Delcath Systems (Nasdaq: DCTH) • Enliven Therapeutics (Nasdaq: ELVN) • Erasca, Inc. (Nasdaq: ERAS) • Immatics (Nasdaq: IMTX) • Janux Therapeutics (Nasdaq: JANX) • MoonLake Immunotherapeutics (NASDAQ: MLTX) • Nuvation Bio (NYSE: NUVB) • Protagonist Therapeutics (Nasdaq: PTGX) • Y-mAbs Therapeutics, Inc. (Nasdaq: YMAB) Read the press release here: https://lnkd.in/etptvWxb

Clear Street is thrilled to announce the formal launch of Clear Street UK following FCA approval and the start of membership in the London Metal Exchange (‘LME’) as a Category 1 Member.  This is a pivotal step in Clear Street’s global expansion plans as we build out our vision to empower clients across all geographies and all financial products. Read the press release here: https://lnkd.in/eCE-nzTg